Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin
about
Applications of nanotechnology in dermatologyMicroneedles: A New Frontier in Nanomedicine DeliveryMicroneedle Coating Techniques for Transdermal Drug DeliveryMicroneedles for intradermal and transdermal drug deliveryPotent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse modelMicroneedle-based drug and vaccine delivery via nanoporous microneedle arraysFormulation of microneedles coated with influenza virus-like particle vaccine.Mechanical strengthening of fiberoptic microneedles using an elastomeric support.Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicityCoating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.Micro- and Nanostructured Biomaterials for Sutureless Tissue Repair.The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunizationMicroneedles for drug and vaccine deliveryInactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.Stability of influenza vaccine coated onto microneedles.Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in micePotent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.Microneedle arrays as medical devices for enhanced transdermal drug delivery.Microneedles: an emerging transdermal drug delivery system.Transcutaneous vaccines--current and emerging strategies.Advanced materials and nanotechnology for drug delivery.Development of the novel coating formulations for skin vaccination using stainless steel microneedle.High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.Microfabrication and in Vivo Performance of a Microdialysis Probe with Embedded Membrane.Controllable coating of microneedles for transdermal drug delivery.Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen.Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid.Getting Drugs Across Biological Barriers.Polymeric microneedles for transdermal protein delivery.
P2860
Q24170384-928EC455-9E28-45E4-AAB4-4A947D19E2BEQ26767037-0B8C8C9C-FEF5-4F08-9149-145252CECFCCQ26778139-4C79A63A-02DE-428E-8AEE-52DF4049F856Q26995148-1AC03F15-DC72-46D3-A43A-09C36ECEA71BQ27330580-6F741A6F-2AD4-4AD0-9284-6CA6DDE0E13BQ28085656-6642F287-E763-4D06-AAF0-F96FAD19A74DQ30392132-B1F27ADE-E083-4FA2-9535-C3A140C14B63Q31055436-A9C92FC5-2A56-47BA-96C7-7130E385B475Q33728320-D0DF2B44-51DB-4E96-B79F-945C29D34B6BQ34288194-A5F25D14-A5BF-4120-A00D-82BC3F5705A6Q34436099-E6F0741C-8BB2-4249-9A7B-59B9ACCC5779Q35219316-DE332CD2-BC64-4B90-9258-CB45DB1E5560Q35811003-6FB3FBCB-0A04-4889-84C6-543450EE9919Q35883584-DA58DD9A-20E4-4B13-AFFC-CF30435607C0Q36037373-4CD2B315-B997-4997-BB96-FA283F892B35Q36164749-4C4EF46B-91DF-45C9-B5F1-8677B21C31F5Q36616041-8A7178AA-254E-400C-A2C4-4F0C160DF515Q36626140-F6E7170F-6B18-4CF9-80DC-0681D42980ECQ36650284-2B137B93-583A-4124-AE17-EACA7C2BE009Q36996938-FFA681F8-2A0A-463F-8918-16697D2E210EQ37087055-88042DBE-88F5-4D85-9FA7-492622075DCAQ37897542-621B9BE8-B049-482F-8A15-CFEC862E7F73Q37965845-E634756D-070C-48FD-AB88-4E4F10083632Q38073800-546A803A-6183-4F84-A77D-FDDBA5061CB1Q38180643-E0D33A38-641B-4B22-B0FE-E6D8D16553D0Q40577779-431E1925-4C9C-4634-9AC4-3B22DC323FC3Q41925081-501C0FF2-5638-4A6E-8853-5F58C0B69239Q42221590-F9AE6FDB-7240-4368-91D5-B2986F588097Q44286234-57898015-1906-452B-9CAD-57FE268781A0Q45287028-34517CE8-F442-481D-AC76-5B0CB96C05DEQ47708661-C43C6857-99BF-4C17-8E96-DD8FCDF3446BQ48331228-28CE70F1-9046-46A7-BC27-4F5A08AFD7A3Q50169459-F5140369-150B-4952-B666-EB4144E27B0A
P2860
Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin
description
article
@en
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2009
@uk
name
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@en
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@nl
type
label
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@en
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@nl
prefLabel
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@en
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@nl
P50
P1476
Dry-coated microprojection arr ...... immunotherapeutics to the skin
@en
P2093
Derek W K Jenkins
Mark A F Kendall
P304
P356
10.1016/J.JCONREL.2009.06.029
P407
P577
2009-07-03T00:00:00Z